Skip to content
The Foxhall Research Unit currently has three active studies:
1. Injectable agent for severe psoriasis (closed to enrollment)
2. Oral medication for severe atopic dermatitis (open to enrollment)
3. Topical medication for contact dermatitis (open to enrollment)
Please call 202-838-3016 if you would like more information regarding these studies.
